Back to Search Start Over

Artificial intelligence guided enhancement of digital PET: scans as fast as CT?

Authors :
Hosch, René
Weber, Manuel
Sraieb, Miriam
Flaschel, Nils
Haubold, Johannes
Kim, Moon-Sung
Umutlu, Lale
Kleesiek, Jens
Herrmann, Ken
Nensa, Felix
Rischpler, Christoph
Koitka, Sven
Seifert, Robert
Kersting, David
Source :
European Journal of Nuclear Medicine & Molecular Imaging. Nov2022, Vol. 49 Issue 13, p4503-4515. 13p. 1 Black and White Photograph, 3 Diagrams, 2 Charts, 1 Graph.
Publication Year :
2022

Abstract

Purpose: Both digital positron emission tomography (PET) detector technologies and artificial intelligence based image post-reconstruction methods allow to reduce the PET acquisition time while maintaining diagnostic quality. The aim of this study was to acquire ultra-low-count fluorodeoxyglucose (FDG) ExtremePET images on a digital PET/computed tomography (CT) scanner at an acquisition time comparable to a CT scan and to generate synthetic full-dose PET images using an artificial neural network. Methods: This is a prospective, single-arm, single-center phase I/II imaging study. A total of 587 patients were included. For each patient, a standard and an ultra-low-count FDG PET/CT scan (whole-body acquisition time about 30 s) were acquired. A modified pix2pixHD deep-learning network was trained employing 387 data sets as training and 200 as test cohort. Three models (PET-only and PET/CT with or without group convolution) were compared. Detectability and quantification were evaluated. Results: The PET/CT input model with group convolution performed best regarding lesion signal recovery and was selected for detailed evaluation. Synthetic PET images were of high visual image quality; mean absolute lesion SUVmax (maximum standardized uptake value) difference was 1.5. Patient-based sensitivity and specificity for lesion detection were 79% and 100%, respectively. Not-detected lesions were of lower tracer uptake and lesion volume. In a matched-pair comparison, patient-based (lesion-based) detection rate was 89% (78%) for PERCIST (PET response criteria in solid tumors)-measurable and 36% (22%) for non PERCIST-measurable lesions. Conclusion: Lesion detectability and lesion quantification were promising in the context of extremely fast acquisition times. Possible application scenarios might include re-staging of late-stage cancer patients, in whom assessment of total tumor burden can be of higher relevance than detailed evaluation of small and low-uptake lesions. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
16197070
Volume :
49
Issue :
13
Database :
Academic Search Index
Journal :
European Journal of Nuclear Medicine & Molecular Imaging
Publication Type :
Academic Journal
Accession number :
159866281
Full Text :
https://doi.org/10.1007/s00259-022-05901-x